Stay updated on SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Sign up to get notified when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.

Latest updates to the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedThe revision adds results-related sections such as Results Posted, Outcome Measures (Results), Adverse Events, Baseline Characteristics, and Participant Flow, along with updated documentation. It also updates Study Status and other study data sections.SummaryDifference2%

- Check21 days agoChange DetectedAdded a site-wide notice about funding and operating status. Updated the revision tag from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check28 days agoChange DetectedThe history page now includes a Show glossary option, color-coded additions and deletions (green/red), and a revision footer showing 'Revision: v3.4.0'.SummaryDifference0.8%

- Check35 days agoChange DetectedThe history adds a 'Results Submitted' entry and removes 'No Results Posted', signaling that trial results have been submitted and are now potentially accessible.SummaryDifference0.1%

- Check42 days agoChange DetectedThe record history shows an added revision 'Revision: v3.3.4' and a removal of 'Revision: v3.3.3', which is a minor administrative update to the history log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter/navigation updates include a new 'Revision: v3.3.3' label and removal of the 'HHS Vulnerability Disclosure' link. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.